Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
-

Safety

  • Share Share this page
-

Stromectol (ivermectin) 3 mg Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

ADVERSE REACTIONS 

Post-Marketing experience 

The following adverse reactions have been reported since the drug was registered overseas: 

  • Onchocerciasis:  Conjunctival hemorrhage 
  • All Indications:  hepatitis
    
-
-
-
-
-